Ingrid Teige, Ph.D.Vice President Preclinical at BioInvent International ABSpeaker
Agenda Sessions
BI-1910 - A TNFR2 Agonist Activating Tumor Targeting T cells for Cancer Immunotherapy
, 09:00View Session